RxDoctor Payments Data

Stuart Head, MD

Vascular & Interventional Radiology · Alexandria, LANPI 1396743712

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 9 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 8 manufacturers reported payments, led by Medtronic at 46.1% of the total. Reporting peaked in 2019 at $320 and has fallen 78.3% since, to $69 in 2025. That places this record below the midpoint for vascular & interventional radiology clinicians in LA, where the typical reported total is $3,137.

$446in general payments, 2019–2025

Across 9 payments — averaging $49.60 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$206
  • Organogenesis Inc.$100
  • GE HealthCare$45
  • Astellas Pharma US Inc$28
  • Bayer$21
  • Merck$18
  • plus $28 from 2 others

What the payments were for

  • Food & beverage$446100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$446 in reported general payments places this provider in the 20th percentile of 42 vascular & interventional radiology providers in Louisiana.

See all vascular & interventional radiology providers in Louisiana

Medicare billing

Part B allowed, 2024
$140,938
Medicare patients
3,150
Services billed
5,422

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other vascular & interventional radiology in Alexandria

See the full list for Louisiana

Where these figures come from

Is this you, or does something look wrong? →